SPY0-72

N/A

Report date: 2026/04/23 20:00:25

Base Information

Drug NameSPY0-72
Drug Alias NameSPY002-072SPY0-72
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor superfamily member 15 inhibitors
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsAxial SpondyloarthritisRheumatic DiseasesArthritis, Rheumatoid +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[8
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSpyre Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSpyre Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsAxial SpondyloarthritisRheumatic DiseasesArthritis, Rheumatoid +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A